Working...
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02502266
Brief Title: Cediranib Maleate and Olaparib or Standard Chemotherapy in Treating Patients With Recurrent Platinum-Resistant or -Refractory Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

First Submitted : July 17, 2015
First Submitted that Met QC Criteria : July 17, 2015
First Posted : July 20, 2015 (Estimate)

Last Update Submitted that Met QC Criteria : May 23, 2019
Last Update Posted : May 24, 2019 (Estimate)